Catherine Riley

602 total citations
8 papers, 481 citations indexed

About

Catherine Riley is a scholar working on Oncology, Otorhinolaryngology and Immunology. According to data from OpenAlex, Catherine Riley has authored 8 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Otorhinolaryngology and 3 papers in Immunology. Recurrent topics in Catherine Riley's work include Immunotherapy and Immune Responses (3 papers), Head and Neck Cancer Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Catherine Riley is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Head and Neck Cancer Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Catherine Riley collaborates with scholars based in United Kingdom, Switzerland and Denmark. Catherine Riley's co-authors include C. J. Randall, Matthew J. Ward, Scott Harris, Nimesh Patel, Emma V. King, Karen Piper Hanley, Toby Mellows, Andrew Webb, Krishna Suchak and Chadwick B. Hampton and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and British Journal of Cancer.

In The Last Decade

Catherine Riley

8 papers receiving 475 citations

Peers

Catherine Riley

ONCOL

IMMUN

MB

OTORH

CR

Rubén Fragoso United States

Götz Lehnerdt Germany

George Koutsodontis Greece

Hyun-Bae Jie United States

Friederike Göke Germany

Gregory T. Wolf United States

David W. Schoppy United States

Yasuyuki Maruse Japan

Emma J. de Ruiter Netherlands

Nour El Houda Agueznay France

Rubén Fragoso United States

Catherine Riley

237 ×0.9

ONCOL

183 ×1.1

IMMUN

111 ×0.7

MB

41 ×0.3

OTORH

39 ×0.5

CR

Citations per year, relative to Catherine Riley Catherine Riley (= 1×) peers Rubén Fragoso

Countries citing papers authored by Catherine Riley

Since Specialization

Citations

This map shows the geographic impact of Catherine Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Riley more than expected).

Fields of papers citing papers by Catherine Riley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Riley. The network helps show where Catherine Riley may publish in the future.

Co-authorship network of co-authors of Catherine Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Riley. A scholar is included among the top collaborators of Catherine Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Riley. Catherine Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ward, Matthew J., Stephen M. Thirdborough, Toby Mellows, et al.. (2013). Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. British Journal of Cancer. 110(2). 489–500. 300 indexed citations

2.

Ward, Matthew J., Toby Mellows, Catherine Riley, Emma V. King, & Gareth J. Thomas. (2013). OP027. Oral Oncology. 49. S14–S14. 2 indexed citations

3.

Davis, Ryan L., et al.. (2013). Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology. 81(21). 1819–1826. 81 indexed citations

4.

Ward, Matthew J., Toby Mellows, Catherine Riley, Emma V. King, & Gareth J. Thomas. (2012). TNM Staging Does Not Predict Survival in HPV‐Positive OPSCC. Otolaryngology. 147(S2). 1 indexed citations

5.

Michael, Agnieszka, Catherine Riley, Shadi Bokaee, et al.. (2011). EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.. Journal of Clinical Oncology. 29(15_suppl). e15528–e15528. 2 indexed citations

6.

John, Justin C. St., Mohamed Ismail, Catherine Riley, et al.. (2010). Differential effects of Paclitaxel on dendritic cell function. BMC Immunology. 11(1). 14–14. 60 indexed citations

7.

Riley, Catherine, et al.. (2009). Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?. Cancer Immunology Immunotherapy. 58(9). 1489–1499. 12 indexed citations

8.

Knights, Ashley, Graham Pawelec, Catherine Riley, et al.. (2007). HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy. 56(12). 1885–1895. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact